GlassScriptPhysician profile
Zhe Hou
NPI 1760800973
$42,842.52
in general payments reported to CMS, 2019-2025
29 companies · $35K in 2025
The $35K reported for 2025 was more than what 95% of Dermatology providers received nationally (typical 2025 total: $772).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $347 · 2020: $1,158 · 2021: $1,669 · 2022: $2,051 · 2023: $905 · 2024: $1,258 · 2025: $35K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $34K · Food and Beverage: $3,133 · Travel and Lodging: $708 · Education: $114.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $33,662.00 |
| Food and Beverage | $3,133.29 |
| Travel and Lodging | $708.20 |
| Education | $114.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Regeneron Healthcare Solutions, INC. | $31,011.61 | 2020-2025 | Libtayo, Dupixent |
| Genzyme Corporation | $6,913.75 | 2020-2025 | |
| Abbvie INC. | $912.26 | 2019-2024 | |
| Leo Pharma INC. | $526.00 | 2020-2025 | Adbry, Anzupgo |
| Pfizer INC. | $496.88 | 2019-2025 | |
| Almirall LLC | $400.00 | 2020 | |
| Galderma Laboratories, L.P. | $363.08 | 2021-2025 | Nemluvio, Aklief |
| Incyte Corporation | $324.84 | 2021-2025 | Opzelura |
| Janssen Biotech, INC. | $263.10 | 2022-2024 | Tremfya, Simponi Aria, Simponi |
| Novartis Pharmaceuticals Corporation | $234.56 | 2020-2024 | |
| Dermavant Sciences, INC. | $214.07 | 2023-2024 | Vtama |
| Amgen INC. | $206.18 | 2020-2023 | Otezla |
| Allergan, INC. | $184.26 | 2019-2020 | |
| Lilly USA, LLC | $163.49 | 2019-2024 | Olumiant |
| Sun Pharmaceutical Industries INC. | $133.14 | 2020-2023 | Odomzo, Blu-U |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $111.25 | 2019-2022 | |
| Biofrontera INC. | $70.60 | 2019-2021 | |
| Arcutis Biotherapeutics, INC. | $66.29 | 2023-2025 | Zoryve |
| Dermira, INC. | $43.54 | 2020 | |
| E.R. Squibb & Sons, L.L.C. | $33.28 | 2024-2025 | Sotyktu |
| Ucb, INC. | $25.70 | 2021 | |
| Merz North America, INC. | $22.68 | 2024 | |
| Mayne Pharma Commercial LLC | $22.04 | 2020 | |
| Verrica Pharmaceuticals INC. | $22.00 | 2025 | Ycanth |
| Misonix INC | $20.40 | 2021 | |
| Vyne Pharmaceuticals INC. | $19.91 | 2020 | |
| Journey Medical Corporation | $18.34 | 2022 | |
| Epi Health, LLC | $14.70 | 2021 | |
| Organon LLC | $4.57 | 2025 | Vtama |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Zhe Hou listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.